Equine Healthcare Market Report 2026

The equine healthcare market size has grown strongly in recent years. It will grow from $1.48 billion in 2025 to $1.58 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising equine population, increasing participation in horse racing and competitive riding, growing awareness of equine health and nutrition, advancements in veterinary drugs and vaccines, expansion of equine healthcare facilities.

The equine healthcare market size is expected to see strong growth in the next few years. It will grow to $2.02 billion in 2030 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to adoption of precision medicine and genomics for equine care, increasing focus on performance enhancement and disease prevention, technological innovations in equine diagnostics, growth in online equine medicine distribution, rising investment in veterinary services for leisure and competitive horses. Major trends in the forecast period include increasing adoption of preventive healthcare and routine veterinary services, growing use of vaccines for core and risk-based equine diseases, rising demand for anti-inflammatories, antibiotics, and pain management drugs, expansion of nutritional supplements, probiotics, and performance enhancers, growth in veterinary hospitals, retail pharmacy, and online distribution channels.

The increasing incidence of zoonotic diseases is expected to drive the growth of the equine healthcare market in the coming years. Zoonotic diseases are infectious conditions caused by pathogens such as viruses, bacteria, parasites, or fungi that can be transmitted between animals and humans. The rise in zoonotic diseases is attributed to closer human-animal interactions, as urbanization, deforestation, and intensive farming practices increase the frequency of contact between people and animals. The equine healthcare market supports this trend, as heightened disease risks lead to greater demand for preventive care, diagnostic solutions, and treatments to safeguard both animal and human health. For example, in December 2025, the European Centre for Disease Prevention and Control, a Sweden-based public health agency, reported that in 2024 the five most frequently reported zoonotic diseases in humans included campylobacteriosis, with 168,396 cases, equivalent to 55.3 cases per 100,000 people. Therefore, the rising incidence of zoonotic diseases is contributing to the growth of the equine healthcare market.

Major companies in the equine healthcare market are concentrating on the development of preventative healthcare programs that offer predictable costs and stress the importance of early treatment. These programs are designed to assist horse owners in managing expenses and encourage the early diagnosis of health issues, thereby enhancing overall equine welfare. For example, in September 2024, Hook Norton Veterinary Group (HNVG Ltd) introduced the Equiplan Gold Health Care Scheme, which aims to improve veterinary services for equines. This scheme focuses on preventative healthcare, specifically targeting horse owners to ensure predictable veterinary costs and promote early intervention for minor issues before they escalate into emergencies. By fostering proactive care, the initiative aims to enhance the overall welfare of horses while reducing financial burdens for their owners.

In January 2024, Altano Group, a veterinary healthcare company based in Canada, acquired McKee Pownall Equine Services for an undisclosed sum. This acquisition underscores Altano’s dedication to improving global equine healthcare by expanding its service offerings and promoting knowledge exchange within the equine veterinary sector. McKee Pownall Equine Services is a Canada-based firm that focuses on performance horse care, general wellness, and emergency veterinary services.

Major companies operating in the equine healthcare market are Merck & Co. Inc., Boehringer Ingelheim, Zoetis Inc., Patterson Companies Inc., Elanco, Idexx Laboratories Inc., Covetrus, Ceva Sante Animale, Virbac, Dechra Pharmaceuticals plc, Vetoquinol, Purina Animal Nutrition LLC, Hilltop BioSciences Inc., Applied Biologics, Addison Biological Laboratory Inc., Hallmarq Veterinary Imaging, Ethos Veterinary Health LLC, Animart LLC, Prisma Imaging, Equine Therapy Solutions, Bayer Animal Health, Heska Corporation, Norbrook Laboratories, Neogen Corporation, Equine Products UK Ltd.

North America was the largest region in the equine healthcare market in 2025. The regions covered in the equine healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the equine healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have impacted the equine healthcare market by increasing costs of imported drugs, vaccines, and medical feed additives, affecting segments such as performance enhancers and medicated feeds, particularly in North America, Europe, and Asia-Pacific. Equine veterinary services and distribution channels are most affected due to import dependencies. While tariffs increase costs, they also encourage local manufacturing and development of equine healthcare products, fostering regional self-reliance and innovation.

The equine healthcare market research report is one of a series of new reports that provides equine healthcare market statistics, including equine healthcare industry global market size, regional shares, competitors with a equine healthcare market share, detailed equine healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the equine healthcare industry. This equine healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Equine healthcare encompasses services and products aimed at treating horses to improve their quality of life, enhance animal food quality, and extend their lifespan. This includes veterinary services for horses used in racing, competitive riding, and leisure, covering routine care such as vaccinations, parasite control, dental care, grooming, hoof care, and protection from natural elements.

Equine healthcare primarily comprises drugs, vaccines, and medical feed additives as its main product types. Drugs, which are pharmacologically active substances, are administered to horses in the event of various diseases such as equine influenza, equine herpes virus, equine encephalomyelitis, West Nile virus, equine rabies, Potomac horse fever, and tetanus. These products are distributed through veterinary hospitals and clinics, retail pharmacies, and online pharmacies.

The equine healthcare market includes revenues earned by entities by taking care of a horse for vaccinations, parasite control, and dental care. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.